Airway consequences of alendronic acid aspiration.

Ear, nose and throat General guidance on prescribing General practice / family medicine Otolaryngology / ENT Safety

Journal

BMJ case reports
ISSN: 1757-790X
Titre abrégé: BMJ Case Rep
Pays: England
ID NLM: 101526291

Informations de publication

Date de publication:
21 Aug 2024
Historique:
medline: 23 8 2024
pubmed: 23 8 2024
entrez: 22 8 2024
Statut: epublish

Résumé

Bisphosphonates are commonly prescribed medications to prevent and treat osteoporosis. Although possessing low side effect profiles, the potential for severe topical effects is rare but important. Irritation of the upper gastrointestinal tract is well documented; however, the risk and effects of accidental aspiration are rarely reported.Attention is drawn to a case recently managed at a tertiary head and neck centre where a patient in their 70s was admitted in respiratory distress 3 days after aspirating alendronic acid. This case highlights the potential risk of topical chemical injury posed to the airway by bisphosphonates.Bisphosphonates should be prescribed with detailed and specific counselling regarding this risk. Pharmacological product literature should be updated to reflect the risk. Clinical teams should be aware of and vigilant for the delayed presentation and prolonged symptom course of such injuries. Prompt airway intervention and techniques to minimise further mucosal trauma ensure optimal outcomes.

Identifiants

pubmed: 39174042
pii: 17/8/e260930
doi: 10.1136/bcr-2024-260930
pii:
doi:

Substances chimiques

Bone Density Conservation Agents 0
Alendronate X1J18R4W8P

Types de publication

Journal Article Case Reports

Langues

eng

Sous-ensembles de citation

IM

Informations de copyright

© BMJ Publishing Group Limited 2024. No commercial re-use. See rights and permissions. Published by BMJ.

Déclaration de conflit d'intérêts

Competing interests: None declared.

Auteurs

Henry Lonsdale (H)

ENT Directorate, Liverpool University Hospitals NHS Foundation Trust, Liverpool, UK hplonsdale@doctors.org.uk.

Rupali Sawant (R)

ENT Directorate, Liverpool University Hospitals NHS Foundation Trust, Liverpool, UK.

Andrew Kinshuck (A)

ENT Directorate, Liverpool University Hospitals NHS Foundation Trust, Liverpool, UK.

Jason Fleming (J)

ENT Directorate, Liverpool University Hospitals NHS Foundation Trust, Liverpool, UK.
University of Liverpool, Liverpool, UK.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH